Miriam Merad, MD, PhD, Elected Fellow of the Accademia Nazionale dei Lincei
Miriam Merad, MD, PhD, has been elected a Fellow of the Accademia Nazionale dei Lincei, Italy’s historic and most prestigious scientific academy. Dr. Merad is one of 46 researchers worldwide chosen for induction in 2025. The new Fellows were formally recognized during a ceremony today in Rome at the opening of the Academy’s 2025–2026 academic year.
Dr. Merad is Dean for Translational Research and Therapeutic Innovation, Chair of the Department of Immunology and Immunotherapy, and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai. She is also Mount Sinai Professor in Cancer Immunology.
An internationally recognized physician-scientist, she has advanced fundamental understanding of the innate immune system, including pioneering discoveries about the development and function of macrophages and dendritic cells in cancer, inflammation, and tissue repair. Her work has illuminated new therapeutic strategies that are transforming immunology and oncology.
Dr. Merad’s election to the Lincei Fellowship caps a year of extraordinary honors:
- In May 2025, she was named a Chevalier de la Légion d’honneur (Knight of the Legion of Honor) by the French government for her pioneering contributions to science and medicine.
- Earlier in 2025, Dr. Merad received the Sjöberg Prize from the Royal Swedish Academy of Sciences for groundbreaking advances in cancer immunology.
Dr. Merad was elected to the National Academy of Sciences (NYAS) in 2020 and the National Academy of Medicine (NYAM) in 2023.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.
The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,700 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 560 postdoctoral research fellows.
Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2025-2026.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.
Lung Cancer Rewires Immune Cells in the Bone Marrow to Weaken Body’s Defenses
Sep 10, 2025 View All Press Releases
Nano Drug Accelerates Diabetic Wound Healing in Mice
May 20, 2024 View All Press Releases
A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
Dec 06, 2023 View All Press Releases
New Lung Immuno-oncology Therapeutic Strategy Identified
Apr 20, 2023 View All Press Releases